
Molecular Residual Disease (MRD): Exploring the impact on cancer early detection and personalized care
Includes a Live Web Event on 10/08/2025 at 1:00 PM (EDT)
-
Register
- General Attendee - Free!
- Speaker - Free!
- Prevent Cancer Foundation Staff - Free!
In this session, delve into the cutting-edge science of Molecular Residual Disease (MRD) testing, a revolutionary approach to cancer detection and treatment guidance. Leaders in the field will discuss the history of MRD – its foundations in clinical medicine – and where the opportunities exist for further research and application. We’ll explore how these tests can help determine prognosis/relapse risk, find early recurrence and individualize treatment to improve patient outcomes.

Heather Parsons, M.D., MPH
Fred Hutchinson Cancer Center

Amir Jazaeri, M.D.
Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center

Jeff Gregg, M.D.
Foresight Diagnostics

Lauren Leiman
BLOODPAC
Key:





This program is planning to offer continuing education credits for Certified Health Education Specialists (CHES), nurses, and advanced practice nurses. Please check back for more details soon!